GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
20.25
+1.44 (7.66%)
At close: Apr 24, 2026, 4:00 PM EDT
20.64
+0.39 (1.93%)
After-hours: Apr 24, 2026, 7:57 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $1.26 billion as of April 24, 2026. Its market cap has increased by 122.53% in one year.
Market Cap
1.26B
Enterprise Value
975.90M
1-Year Change
122.53%
Ranking
Category
Stock Price
$20.25
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.26B, an increase of 55.39%. That is a compound annual growth rate of 9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 1.26B | 59.45% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jade Biosciences | 1.26B |
| AbCellera Biologics | 1.26B |
| Aktis Oncology | 1.21B |
| Pharming Group | 1.20B |
| MoonLake Immunotherapeutics | 1.19B |
| UroGen Pharma | 1.19B |
| EyePoint | 1.16B |
| DBV Technologies | 1.16B |